Cas9 protein delivery non-integrating lentiviral vectors for gene correction in sickle cell disease
Naoya Uchida(National Heart Lung and Blood Institute), John F. Tisdale(National Institutes of Health), Jackson Gamer(National Institute of Diabetes and Digestive and Kidney Diseases), Selami Demirci(National Heart Lung and Blood Institute), Yoshitaka SHIBATA(National Institutes of Health), Juan J. Haro‐Mora(National Institutes of Health), Claire Drysdale(National Institute of Diabetes and Digestive and Kidney Diseases), Tina Nassehi(National Institute of Diabetes and Digestive and Kidney Diseases), Morgan Yapundich(National Institute of Diabetes and Digestive and Kidney Diseases), Malikiya Hinds(National Institutes of Health), Julia DiNicola(National Institutes of Health)
Cited by 51
Related Papers
Antimicrobial Properties of Zeolite-X and Zeolite-A Ion-Exchanged with Silver, Copper, and Zinc Against a Broad Range of Microorganisms
|Applied Biochemistry and Biotechnology|2013|173
Boron and Poloxamer (F68 and F127) Containing Hydrogel Formulation for Burn Wound Healing
|Biological Trace Element Research|2015|114
Gene therapy for sickle cell disease: An update
|Cytotherapy|2018|114
Boron promotes streptozotocin-induced diabetic wound healing: roles in cell proliferation and migration, growth factor expression, and inflammation
|Molecular and Cellular Biochemistry|2016|101
Hematopoietic stem cells from pluripotent stem cells: Clinical potential, challenges, and future perspectives
|Stem Cells Translational Medicine|2020|82